Texas v. Janssen (Risperdal)

SETTLED

Trial
01/09/12 – 01/19/12

Summary

In this pharmaceutical fraud litigation proceeding, plaintiff State of Texas (ex rel Allen Jones alleged Jannes L.P. (subsidiary of Johnson & Johnson) of defrauding the Medicaid program through its off-label promotion of the atypical antipsychotic drug Risperdal. The plaintiff’s counsels claimed that Janssen misrepresented the risks and approved used of Risperdal, including use in children and that the State of Texas was defrauded by having to pay for Medicaid prescriptions for Risperdal for off-label uses, costing the state millions.

The plaintiff was represented by attorneys Cynthia O’ Keefe, Thomas Melsheimer, Tommy Jacks, Patrick Sweeten, Natalie Arbaugh. The defendant in this case, Jonson & Johnson was represented by attorneys Stephen McConnico, Bryan Lauer, John McDonald and Steve Wingard.

Outcome

Settled.

Sessions

JAN
12
JAN
18

Recording Disclaimer: This proceeding was recorded in full.

AudioCaseFiles

Exclusive audio opinions to enhance your law school experience

AudioCaseFiles

Essentials

The most important and informative moments of each trial

Essentials

Training Libraries

Trial Advocacy, Rules of Evidence and Appellate Advocacy

Training

  • Follow Us